Back
Cartesian Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$6.90
Seasonality Move:
7.79%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCartesian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 22% based on the past 9 years of stock performance.
-
Cartesian Therapeutics, Inc. has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Cartesian Therapeutics, Inc. Stock Undervalued?The current Cartesian Therapeutics, Inc. [RNAC] share price is $6.90. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 22% based on the past 9 years of stock performance.
Cartesian Therapeutics, Inc. Stock Rating
Sell
37
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. overpriced?
-
Cartesian Therapeutics, Inc. has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Cartesian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
26.50
52-Week Low:
5.98
Prediction Charts
Market Cap:
179.4M
Price in USD:
6.90
Volume:
364.8K
Beta:
0.85
Technical Analysis
SMA50:
8.47
SMA100:
9.81
SMA200:
11.18
52-Wk Change:
-68.64%
Stock Predictions
-
Is Cartesian Therapeutics, Inc. stock public?Yes, Cartesian Therapeutics, Inc. is a publicly traded company.
-
What is the Cartesian Therapeutics, Inc. stock quote today?The Cartesian Therapeutics, Inc. stock price is 6.90 USD today.
-
How to buy Cartesian Therapeutics, Inc. stock online?You can buy Cartesian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 7.50 | 7.46 | 7.88 | 7.24 |
| Nov-17 | 7.45 | 7.38 | 7.83 | 7.36 |
| Nov-18 | 7.36 | 7.62 | 7.71 | 7.34 |
| Nov-19 | 7.55 | 7.15 | 7.73 | 7.11 |
| Nov-20 | 7.31 | 7.15 | 7.69 | 7.13 |
| Nov-21 | 7.16 | 7.24 | 7.40 | 7.06 |
| Nov-24 | 7.25 | 7.43 | 7.54 | 7.11 |
| Nov-25 | 7.43 | 7.32 | 7.57 | 7.24 |
| Nov-26 | 7.28 | 7.60 | 7.61 | 7.23 |
| Nov-28 | 7.62 | 7.49 | 7.73 | 7.44 |
| Dec-1 | 7.41 | 7.30 | 7.57 | 7.20 |
| Dec-2 | 7.31 | 6.71 | 7.31 | 6.60 |
| Dec-3 | 6.72 | 6.65 | 6.94 | 6.58 |
| Dec-4 | 6.62 | 6.90 | 7.00 | 6.53 |
Cartesian Therapeutics, Inc. Earnings
Cartesian Therapeutics, Inc. Earnings Report: Per Share Cartesian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics, Inc. Forecast Revenue Growth
Cartesian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.19 per share, and a decrease next year of $0.65 per share.
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.